This inventor holds 29 USPTO granted patents, primarily in Nanotechnology Applications. Top assignees: Eastman-Kodak Company, Cerion LLC, Cerion Enterprises LLC. Active years: 1992-2023.
Location History:
- Wesbter, NY (US) (1994 - 1995)
- Webster, NY (US) (1992 - 2023)
Company Filing History:
23 out of 21,604Â 
5 out of 24Â 
1 out of 1Â Years Active: 1992-2023
Areas of Expertise:
Title: **Eric L. Bell: Pioneering Advances in Nanoparticle Technologies**
Introduction
Eric L. Bell, an accomplished inventor based in Webster, NY, has made significant contributions to the field of biocompatible nanoparticles with a remarkable portfolio of 29 patents. His work primarily focuses on innovative processes for creating nanoparticles that demonstrate unique properties and applications in medical science.
Latest Patents
Among his latest patents, Eric has developed Edds chelated nanoceria with catalase-like activity. This invention outlines a process for making nanoparticles of biocompatible materials using a specific mixture of cerous ion and ethylenediaminedisuccinic acid, combined with an oxidant and water, resulting in a stable dispersion of cerium oxide nanoparticles enhanced with catalase-like enzyme activity. Another significant patent involves a novel procedure for producing nanoceria intended for neutralizing free radicals. This patent describes a similar approach using cerous ion, citric acid, and ethylenediaminetetraacetic acid in predetermined ratios, aimed at designing biocompatible nanoparticles crucial for preventing and treating oxidative stress-related diseases such as stroke and multiple sclerosis.
Career Highlights
Eric has built his career through notable positions at Eastman Kodak Company and Cerion LLC, where he utilized his expertise in materials science and nanotechnology to drive innovative research and development projects. His ability to translate complex scientific principles into practical applications has positioned him as a significant figure in the field.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including Jerzy Z. Mydlarz and Kenneth Joseph Reed. These partnerships have fostered a collaborative environment that enhances the depth and breadth of research in the field of nanoparticle technology.
Conclusion
Eric L. Bell continues to push the boundaries of innovation in nanoparticle research, demonstrating how science can translate into life-enhancing applications. His extensive portfolio of patents and collaborative spirit indicate a steadfast commitment to advancing medical and technological frontiers, solidifying his reputation as a leading inventor in the industry.